Radio 4 Inside Health interview
Chair Jonathan Pearce is interviewed on BBC Radio 4's Inside Health Programme on the Cancer Drug Fund and the extra challenges faced by...
top of page
In response to the National Audit Offices Investigation into Cancer Drugs Fund report
Jonathan Pearce, Chair of Cancer52, said: "Cancer52 calls on NHS England to learn from The National Audit Office’s report[1] and ensure...
Cancer Drug Fund Delistings
Cancer52 comment on Cancer Drug Fund announcement of 4 September 2015.
Cancer52 Policy Briefing identifies calls for rare and less common cancers
The Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020 was published in July 2015. Cancer52, a coalition of more...
“Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013”
We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...
Proposed changes to the Standard Operating Procedures: Cancer Drugs Fund 2015-16
On 15th June 2015, Cancer52 responded to the proposed changes to the Standard Operating Procedures: Cancer Drugs Fund 2015-16. In...
“Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013”
We are delighted to announce that our new report “Rare and Less Common Cancers: Incidence and Mortality in England, 2010 to 2013” is...
Parliamentary Questions and Answers
Following our successful Parliamentary event in December, details of how the last government answered our questions on rare and less...
NHS Consultation on Investing in Specialised Services
On 23rd April 2015, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. In summary Cancer52 believes...
Consultation on Investing in Specialised Services
On 23 April, Cancer52 responded to the NHS public consultation on Investing in Specialised Services. Read more of our submission.
bottom of page